Alternatives to ParcelBio
ParcelBio is a Biotechnology tool: advancing next-generation mRNA medicines. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to ParcelBio
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
BioNTech66BiotechnologyMainz, Germany$975.0MGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
- Website
Network Bio60BiotechnologyPalo Alto, United States$100.0MLeveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
Mironid59BiotechnologyGlasgow, United Kingdom$46.0MBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
- Website
Spark Therapeutics58BiotechnologyPhiladelphia, United States$82.8MA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
- EAEarendil Labs56BiotechnologyBeijing, China$787.0M
Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.
- Website
Transcripta Bio54BiotechnologyPalo Alto, United States$24.0MAI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.
- Website KHKhartis Therapeutics, Inc.53BiotechnologySan Diego, United States$50.0M
Developing oral small molecule medicines for immunological and chronic diseases.
- Website
Waypoint Bio53BiotechnologyNew York, USA$20.0MAI-native biotech company designing next-generation CAR T therapies for solid tumors.
- Website
Immix Biopharma, Inc.51BiotechnologyLos Angeles, United States$5.0MA clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.
- Website
Cartography Biosciences49BiotechnologySouth San Francisco, USA$150.0MA biotechnology company focused on oncology drug discovery.
- Website CICity Therapeutics48BiotechnologyCambridge, USA$99.5M
A biopharmaceutical company developing RNA interference (RNAi)-based medicines.
- Website
Immitra Bio48BiotechnologyZürich, Switzerland$2.6MScalable, one-time curative in-vivo gene editing therapies.
- Website TOTolemy Bio46BiotechnologyCambridge, United Kingdom$1.4M
AI-enabled technology for cell biology research and biopharma development.
- Website
Exobiosphere45BiotechnologyEsch-sur-Alzette, Luxembourg$3.2MSpace BioTech startup developing an autonomous, high-throughput screening platform for drug discovery in microgravity.
- Website
Houdini Bio42BiotechnologyCambridge, United Kingdom$1.7MEngineering-driven DNA design platform to overcome biological barriers in genetic medicines.
- Website
InduPro, Inc.39BiotechnologySeattle, United States$77.0MBiotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.
- Website
Mammoth Biosciences63BiotechnologyBrisbane, United States$460.0MBiotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.
- Website
Pixelgen Technologies62BiotechnologyStockholm, Sweden$43.5MA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Showing the 20 closest matches. See the rest on the ParcelBio profile.
Compare ParcelBio head to head
Side by side on what each one does, what it costs, and what real users report.